Using data to outpace disease

We designed our technology and services platform for precision and flexibility. Driven by data and FDA-cleared algorithms, the Biofourmis Platform delivers interventions personalized to the individual and their disease. It’s configurable and scaleable, to adapt to the needs of your organization and patient populations. For all aspects of drug development and care delivery, the Biofourmis Platform helps make care simpler, science smarter, and patients healthier.

We designed our technology and services Platform for precision and flexibility. Driven by data and FDA-cleared algorithms, the Biofourmis platform delivers interventions personalized to the individual and their disease. It’s configurable and scaleable, to adapt to the needs of your organization and patient populations. For all aspects of drug development and care delivery, the Biofourmis platform helps make care simpler, science smarter, and patients healthier.

21

Proprietary AI algorithms developed for care delivery and life sciences¹

70+

Remote dynamic care pathways based on diseases, acuity, and clinical goals²

How our platform works

Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.

Data

Collect and Aggregate

Through biosensor data collection, we use vital signs to create unique and aggregate biomarkers that continuously represent the clinical status of the patient.

Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.

ANALYTICS

Detect and Predict

Our FDA-cleared algorithms generate a personalized baseline for each patient and detect clinical deviation. By recognizing clinically meaningful fluctuations, our AI-driven analytics can predict deterioration early, so that it can be proactively addressed.

Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.

INTERVENTIONS

Treat and Track

Our platform facilitates personalized interventions through a user-friendly dashboard and communication interface. Dynamic care pathways are designed to improve outcomes by managing each patient according to disease, acuity level, and clinical goals. Collectively, these tools help manage, escalate, and track care throughout the program.

Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.

INNOVATION and OUTCOMES

Care and Connect

Our AI-guided algorithms continuously learn and adjust, so that patients receive the right care at the right time. Technology-enabled remote and in-home support includes care coordination, nursing, and diagnostics—all configurable to augment your organization’s needs to deliver personalized care across the care continuum, from drug development to care delivery.

Infinity symbol that demonstrates relationship between data, intervention, innovation, and analytics with people at center.
4M+

Data points captured per post-acute care patient per day for precise treatment¹

100K

Patients served across Biofourmis solutions¹

Our platform features

Device connectivity

Our platform connects medical-grade clinical devices and sensors for physiology monitoring in homes, hospitals, and clinics.

Continuous monitoring of patient health status 

Device-agnostic, simplifying integration with your existing systems and tools

Operates through cellular connection

Data science

Remote data collection, a robust data lake, and advanced analytics provide a rich foundation to develop and deliver cutting-edge data science for innovative patient care. 

Library of digital biomarkers and clinical measures

100K patients served across Biofourmis solutions

AI-driven, FDA-cleared algorithm models each patient’s personalized vitals baseline and identifies clinically significant deviations

Engagement

Our customizable digital tools offer features such as interactive content, progress updates, and compliance monitoring to help ensure care delivery is both seamless and timely.

The patient mobile app tracks daily care plan, vital signs, symptoms, and medications; facilitates virtual visits and communications with clinical teams; offers education and guidance

Physician and investigator dashboard allows clinicians to view notifications, communicate with patients, conduct triage, and manage medications

Personalized interventions

FDA-cleared analytics help care teams deliver proactive interventions for each patient while decreasing clinician burden.

70+ remote dynamic care pathways with intervention protocols such as care team outreach, vital sign checks, and symptom specific feedback

Software-based medication optimization following clinical guidelines

AI algorithms can reduce notification burden by up to 80%1

Care coordination

Our platform integrates tools that streamline care and simplify information sharing.

Appointment and lab scheduling managed by Biofourmis Health Navigators

Visit and medication reminders integrated into patient app

EMR integration includes data from patient monitoring questionnaires, notifications, in-home support, and reference billing documentation

Clinical and in-home services

Our network of clinicians and service partners completes the care continuum, ensuring that you can configure a full slate of services to fulfill patients' needs.* 

Health navigators, registered nurses, and advanced practitioners evaluate and manage clinical escalations; available 24/7/365

Services include nursing, paramedicine, infusion, and mobile imaging

Ancillary services include transportation, meal service, durable medical equipment, and waste management

Care coordination tools for clinical teams, clinical vendors, and device inventory

“If you think about the fundamentals of technology and the definition of health, it has to be affordable, acceptable, and accessible. There are still problems with access to care and affordability. So the question for us is, can you use technology to close that gap?”

Maulik Majmudar, MD
Biofourmis Co-founder and Chief Medical Officer

1. Biofourmis Data on file.
2. Un, KC., Wong, CK., Lau, YM.etal.Observational study on wearable biosensors
and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11,
4388 (2021). https://doi.org/10.1038/s41598-021-82771-7.

*Subject to geography and connectivity